Nitric oxide inhibition rapidly increases blood pressure with no change in outcome in cardiogenic shock: The TRIUMPH trial

Critical Care

Volumn 11, Issue 3, 2007, Pages

  Salem, Réda ^a   Mebazaa, Alexandre ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO; TILARGININE; ARGININE; DRUG DERIVATIVE; N(G) MONOMETHYLARGININE ACETATE; N(G)-MONOMETHYLARGININE ACETATE; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; BOLUS INJECTION; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; AGED; ARTICLE; BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ARGININE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 40749148903     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5925     Document Type: Note

References (13)

1. Alexander JH Reynolds HR Stebbins AL Dzavik V Harrington RA Van de Werf F Hochman JS Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial JAMA 2007, 297:1657-1666. 10.1001/jama.297.15.joc70035 17387132
2. Goldberg RJ Samad NA Yarzebski J Gurwitz J Bigelow C Gore JM Temporal trends in cardiogenic shock complicating acute myocardial infarction N Engl J Med 1999, 340:1162-1168. 10.1056/NEJM199904153401504 10202167
3. Hochman JS Sleeper LA Webb JG Sanborn TA White HD Talley JD Buller CE Jacobs AK Slater JN Col J SHOCK Investigators Early revascularization in acute myocardial infarction complicated by cardiogenic shock N Engl J Med 1999, 341:625-634. 10.1056/NEJM199908263410901 10460813
4. Mallory GK White PD The speed of healing of myocardial infarction Am Heart J 1939, 18:647-671. 10.1016/S0002-8703(39)90845-8
5. Wildhirt AM Dudek RR Suzuki H Bing RJ Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction Int J Cardiol 1995, 50:253-261. 10.1016/0167-5273(95)02385-A 8537149
6. Hochmann JS Cardiogenic shock complicating myocardial infarction: expanding the paradigm Circulation 2003, 107:2998-3002. 10.1161/ 01.CIR.0000075927.67673.F2 12821585
7. Frangogiannis FG Smith CW Entman ML The inflammatory response in myocardial infarction Cardiovasc Res 2002, 53:31-47. 10.1016/ S0008-6363(01)00434-5 11744011
8. Kohsaka S Menon V Lowe AM Lange M Dzavik V Sleeper LA Hochmann JS SHOCK Investigators Systemic response syndrome after acute myocardial infarction complicated by cardiogenic shock Arch Intern Med 2005, 165:1643-1650. 10.1001/archinte.165.14.1643 16043684
9. Ndrepepa G Schomig A Kastrati A Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: Looking for the reasons JAMA 2007, 297:1711-1713. 10.1001/jama.297.15.1711 17440148
10. Dzavik V Cotter G Reynolds HR Alexander JH Ramanathan K Stebbins AL Hathaway D Farkouh ME Ohman EM Baran DA Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: A phase II dose-ranging study Eur Heart J 2007, 28:1109-1116. 10.1093/eurheartj/ ehm075 17459901
11. López A Lorente JA Steingrub J Bakker J McLuckie A Willatts S Brockway M Anzueto A Holzapfel L Breen D Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock Crit Care Med 2004, 32:21-30. 10.1097/01.CCM.0000105581.01815.C6 14707556
12. Cotter G Kaluskia E Milo O Blatt A Salah A Hendler A Krakover R Golick A Vered Z LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock. A prospective randomized study Eur Heart J 2003, 24:1287-1295. 10.1016/S0195-668X(03)00193-3 12871685
13. Rabuel C Mebazaa A Septic shock: A heart story since the 60's Intensive Care Med 2006, 32:799-807. 10.1007/s00134-006-0142-5 16570145